![5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one structure](/static/products/292/292064-54-1.png)
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one
概要：5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one（CAS 292064-54-1）是一种化学化合物，分子式为C31H32ClN3O2，分子量为513.22 g/mol。河南科弘生物科技有限公司提供CRO/CDMO定制合成服务，支持克级到吨级规格。
5-[2-(4-chlorophenyl)acetyl]-6-[4-(dimethylamino)phenyl]-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one
又称：5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one, 10-[(4-chlorophenyl)acetyl]-11-[4-(dimethylamino)phenyl]-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one, 10-(2-(4-chlorophenyl)acetyl)-11-(4-(dimethylamino)phenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one, 10-[2-(4-CHLOROPHENYL)ACETYL]-11-[4-(DIMETHYLAMINO)PHENYL]-3,3-DIMETHYL-2,3,4,5,10,11-HEXAHYDRO-1H-DIBENZO[B,E][1,4]DIAZEPIN-1-ONE, 2-(4-chlorophenyl)-1-{11-[4-(dimethylamino)phenyl]-1-hydroxy-3,3-dimethyl-2,3,4,11-tetrahydro-10H-dibenzo[b,e][1,4]diazepin-10-yl}ethanone
| 分子式 | C31H32ClN3O2 |
|---|---|
| 分子量 | 513.22 g/mol |
| LogP | 6.7917 |
| 拓扑极性表面积 | 52.65 Ų |
| 氢键供体数 | 1 |
| 氢键受体数 | 4 |
| 可旋转键数 | 4 |
| 精确质量 | 513.2183 |
| 重原子数 | 37 |
| 复杂度 | 1374.3219 |
化学标识符
| CAS 编号 | 292064-54-1 |
|---|---|
| SMILES | CC1(CC2=C(C(N(C3=CC=CC=C3N2)C(=O)CC4=CC=C(C=C4)Cl)C5=CC=C(C=C5)N(C)C)C(=O)C1)C |
产品概述
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one（CAS 292064-54-1），分子式为C31H32ClN3O2，分子量为513.22 g/mol。IUPAC名：5-[2-(4-chlorophenyl)acetyl]-6-[4-(dimethylamino)phenyl]-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one。
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one化学性质概览
属性洞察：5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的XLogP值为6.7917，表明该化合物具有亲脂性（脂溶性好），可能影响其吸收、分布和配方策略。 5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的拓扑极性表面积（TPSA）为52.65 Ų，极性较低，可能具有较好的细胞膜透过性。 根据Lipinski五规则，5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one有1个氢键供体和4个氢键受体，可能需要考虑配方优化。
常见问题
常见问题
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的CAS号是多少？
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的CAS号为292064-54-1。
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的分子式是什么？
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的分子式为C31H32ClN3O2。
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的分子量是多少？
5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的分子量为513.22 g/mol。
在哪里可以购买5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one？
您可以直接向科弘生物询价5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one。联系我们或发送邮件至info@kehongbio.com获取报价和库存信息。
科弘生物是否提供5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one的定制合成服务？
是的，科弘生物提供5-[2-(4-chlorophenyl)acetyl]-6-(4-dimethylaminophenyl)-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one及相关化合物的定制合成服务。请联系我们并告知您的具体需求，包括数量、纯度和交期。